The article focuses on the addition of the cholesterol-lowering drugs such as PCSK9 inhibitors Praluent and Repatha to the National Preferred Formulary of Express Scripts, a pharmacy benefit management organization.doi:10.1007/s40274-015-2548-1None...
“It’s our job to find the right digital health solutions for our clients and patients, and then make sure patients use these solutions effectively,” Mark Bini, chief patient experience officer for Express Scripts, said in a news release. “With the Express Scripts Digital Health Fo...
Boehringer Ingelheim’s Interchangeable biosimilar now included on Express Scripts National Preferred Formulary
Injury-SpecificLimitsformularystatustomedicationsthataremoreappropriatetoaninjuredworker’sspecificinjury,•Efficacy Formularysuchasburnsandeyetrauma•Costcontrolofinappropriate prescriptions ) r e h t O• (PriorAuthorizationUsingOASIS–theExpressScriptsproprietary,automated,web-basedtool–clientsdetermine...
Express Scripts Holding Co. (NASDAQ:ESRX) announced its 2019 National Preferred Formulary Exclusions, noting that the exclusions were driven not only by t...
“It’s our job to find the right digital health solutions for our clients and patients, and then make sure patients use these solutions effectively,” Mark Bini, chief patient experience officer for Express Scripts, said in a news release. “With the Express Scripts Digital Health Formulary, ...
Express Scripts and AbbVie Ink Landmark Formulary Exclusivity DealRandi Hernandez
How Express Scripts will manage pricey cholesterol drugsChristine BlankContributing Editor
Express Scripts may switch hepatitis C drugs on preferred formularyWhile pharmaceutical manufacturer AbbVie's new hepatitis C drug has not yet been approved by FDA, pharmacy benefits manager Express Scripts has expressed interest in switching to the drug in its preferred drug formula...
Cathy Kelly